RAPT Therapeutics, Inc. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RAPT Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in RAPT Therapeutics, Inc. for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2019 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 155,201 | 0 | 0 | |
| Nov 15 2019 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 363,504 | 0 | 0 | |
| Nov 15 2019 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,641,666 | 0 | 0 | |
| Nov 15 2019 | RAPT | RAPT Therapeutics, ... | Topspin Fund L.P. | 10% Owner | Buy | P | 12.00 | 415,000 | 4,980,000 | 2,575,371 | 2.2 M to 2.6 M (+19.21 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Buy | P | 12.00 | 1,600 | 19,200 | 1,600 | 0 to 1.6 K |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 872,410 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 872,410 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 8,724,100 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 4,362,050 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 14,781,963 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 145,401 | 0 | 145,401 | 0 to 145.4 K |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 145,401 | 0 | 1,599,417 | 1.5 M to 1.6 M (+10.00 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 1,454,016 | 0 | 1,454,016 | 0 to 1.5 M |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | P | 12.00 | 625,000 | 7,500,000 | 4,982,333 | 4.4 M to 5 M (+14.34 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 727,008 | 0 | 4,357,333 | 3.6 M to 4.4 M (+20.03 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 1,166,666 | 0 | 3,630,325 | 2.5 M to 3.6 M (+47.36 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 2,463,659 | 0 | 2,463,659 | 0 to 2.5 M |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Option Exercise | C | 0.00 | 150,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Buy | P | 12.00 | 25,000 | 300,000 | 125,000 | 100 K to 125 K (+25.00 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Buy | C | 0.00 | 25,000 | 0 | 355,000 | 330 K to 355 K (+7.58 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | C | 0.00 | 260,344 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Buy | P | 12.00 | 8,000 | 96,000 | 8,000 | 0 to 8 K |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Buy | C | 0.00 | 16,666 | 0 | 76,722 | 60.1 K to 76.7 K (+27.75 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Buy | C | 0.00 | 43,390 | 0 | 60,056 | 16.7 K to 60.1 K (+260.35 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 872,410 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 2,181,025 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 17,228,956 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 145,401 | 0 | 3,547,063 | 3.4 M to 3.5 M (+4.27 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 363,504 | 0 | 3,401,662 | 3 M to 3.4 M (+11.96 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 166,666 | 0 | 3,038,158 | 2.9 M to 3 M (+5.80 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 2,871,492 | 0 | 2,871,492 | 0 to 2.9 M |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 872,410 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 872,410 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 8,724,100 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 4,362,050 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 14,781,963 | 0 | 0 | |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 145,401 | 0 | 145,401 | 0 to 145.4 K |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 145,401 | 0 | 1,599,417 | 1.5 M to 1.6 M (+10.00 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 1,454,016 | 0 | 1,454,016 | 0 to 1.5 M |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | P | 12.00 | 625,000 | 7,500,000 | 4,982,333 | 4.4 M to 5 M (+14.34 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 727,008 | 0 | 4,357,333 | 3.6 M to 4.4 M (+20.03 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 1,166,666 | 0 | 3,630,325 | 2.5 M to 3.6 M (+47.36 %) |
| Nov 04 2019 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 2,463,659 | 0 | 2,463,659 | 0 to 2.5 M |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Kozick Linda | Director | Option Exercise | A | 12.00 | 3,333 | 39,996 | 3,333 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Kozick Linda | Director | Option Exercise | A | 12.00 | 15,334 | 184,008 | 15,334 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Kozick Linda | Director | Option Exercise | A | 12.00 | 3,333 | 39,996 | 3,333 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Kozick Linda | Director | Option Exercise | A | 12.00 | 15,334 | 184,008 | 15,334 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | HO WILLIAM | Chief Medical Offic ... | Option Exercise | A | 12.00 | 22,083 | 264,996 | 22,083 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Wong Brian Russell | President and CEO | Option Exercise | A | 12.00 | 83,333 | 999,996 | 83,333 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 12.00 | 3,333 | 39,996 | 3,333 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 12.00 | 15,334 | 184,008 | 15,334 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Giordano Michael F | Director | Option Exercise | A | 12.00 | 15,334 | 184,008 | 15,334 | |
| Nov 01 2019 | RAPT | RAPT Therapeutics, ... | Robbins Wendye | Director | Option Exercise | A | 12.00 | 32,000 | 384,000 | 32,000 |